172 related articles for article (PubMed ID: 17072949)
1. p21 and p27 immunoexpression in gastric well differentiated endocrine tumors (ECL-cell carcinoids).
Doganavsargil B; Sarsik B; Kirdok FS; Musoglu A; Tuncyurek M
World J Gastroenterol; 2006 Oct; 12(39):6280-4. PubMed ID: 17072949
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells.
Srivastava A; Kamath A; Barry SA; Dayal Y
Endocr Pathol; 2004; 15(1):47-54. PubMed ID: 15067176
[TBL] [Abstract][Full Text] [Related]
3. Deletion of
Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
[TBL] [Abstract][Full Text] [Related]
4. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior.
Canavese G; Azzoni C; Pizzi S; Corleto VD; Pasquali C; Davoli C; Crafa P; Delle Fave G; Bordi C
Hum Pathol; 2001 Oct; 32(10):1094-101. PubMed ID: 11679944
[TBL] [Abstract][Full Text] [Related]
5. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
[TBL] [Abstract][Full Text] [Related]
6. Multiple gastric carcinoids and endocrine cell micronests in type A gastritis: Nuclear morphometric and immunohistochemical analysis.
Iwai K; Yao T; Nakamura S; Matsumoto T; Nishiyama K; Iida M; Tsuneyoshi M
Oncol Rep; 2005 Mar; 13(3):397-404. PubMed ID: 15706407
[TBL] [Abstract][Full Text] [Related]
7. Gastric carcinoids.
Bordi C
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S94-7. PubMed ID: 10604110
[TBL] [Abstract][Full Text] [Related]
8. Gastric carcinoid tumors, endocrine cell hyperplasia, and associated intestinal metaplasia. Histologic, histochemical, and immunohistochemical findings.
Mendelsohn G; de la Monte S; Dunn JL; Yardley JH
Cancer; 1987 Sep; 60(5):1022-31. PubMed ID: 2440553
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of Skp2 expression in gastric carcinoma to expression of P27 and PTEN].
Ma XM; Liu JH; Guo JW; Liu Y; Zuo LF
Ai Zheng; 2006 Jan; 25(1):56-61. PubMed ID: 16405750
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of forkhead box M1 and its downstream cyclin-dependent kinase inhibitors p27(kip1) and p21(waf1/cip1) in the diagnosis of pulmonary neuroendocrine tumours.
Ha SY; Lee CH; Chang HK; Chang S; Kwon KY; Lee EH; Roh MS; Seo B
Histopathology; 2012 Apr; 60(5):731-9. PubMed ID: 22296117
[TBL] [Abstract][Full Text] [Related]
11. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A.
Müller J; Kirchner T; Müller-Hermelink HK
Am J Surg Pathol; 1987 Dec; 11(12):909-17. PubMed ID: 3318512
[TBL] [Abstract][Full Text] [Related]
12. [Study on histogenesis of enterochromaffin-like carcinoid in autoimmune atrophic gastritis associated with pernicious anemia].
Macukanović-Golubović L; Katić V; Rancić G; Milenović M; Marjanović G; Golubović Z
Vojnosanit Pregl; 2007 Aug; 64(8):543-8. PubMed ID: 17874722
[TBL] [Abstract][Full Text] [Related]
13. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid.
Annibale B; Azzoni C; Corleto VD; di Giulio E; Caruana P; D'Ambra G; Bordi C; Delle Fave G
Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1449-56. PubMed ID: 11742193
[TBL] [Abstract][Full Text] [Related]
14. [Expression of cyclin dependent kinase inhibitors of KIP family in gastric cancer].
Lee SJ; Joo YE; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
Korean J Gastroenterol; 2005 Aug; 46(2):84-93. PubMed ID: 16118517
[TBL] [Abstract][Full Text] [Related]
15. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
Agoston AT; Odze RD
Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
[TBL] [Abstract][Full Text] [Related]
16. Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia.
Higham AD; Bishop LA; Dimaline R; Blackmore CG; Dobbins AC; Varro A; Thompson DG; Dockray GJ
Gastroenterology; 1999 Jun; 116(6):1310-8. PubMed ID: 10348814
[TBL] [Abstract][Full Text] [Related]
17. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
18. Relationship of ECL cells and gastric neoplasia.
Waldum HL; Brenna E; Sandvik AK
Yale J Biol Med; 1998; 71(3-4):325-35. PubMed ID: 10461363
[TBL] [Abstract][Full Text] [Related]
19. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
[TBL] [Abstract][Full Text] [Related]
20. P21
Dong W; Li J; Liu Q; Liu C; Li C; Song G; Zhu H; Gao H; Zhang Y
J Neurooncol; 2018 Feb; 136(3):485-494. PubMed ID: 29230669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
